Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile
Clinical trial NCT05593042 · COMPLETED
Trial details
- NCT number
- NCT05593042
- Sponsor
- Pontificia Universidad Catolica de Chile
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2023-10-26
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.